Anti‐TNF medications are used to treat a number of other immune‐mediated inflammatory diseases, which together affect about 5%–7% of Western populations including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, hidradenitis suppurativa and uveitis.28 The gene discussed is TNF; the disease is psoriatic arthritis.